News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
ENDEAVOR IV: Zotarolimus- and Paclitaxel-eluting Stents Demonstrated Similar Safety, Efficacy
February 2, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Cardiology Today -- The zotarolimus- and paclitaxel-eluting stents had similar safety and efficacy at one year in patients with coronary artery disease.
Twitter
LinkedIn
Facebook
Email
Print
